Literature DB >> 22008651

Association of HIV infection with spontaneous and iatrogenic preterm delivery: effect of HAART.

Marta Lopez1, Francesc Figueras, Sandra Hernandez, Montserrat Lonca, Raul Garcia, Montse Palacio, Oriol Coll.   

Abstract

OBJECTIVES: To assess the association between HIV infection and both spontaneous and iatrogenic preterm delivery (PTD), and to explore the impact of HAART on both entities.
METHODS: A matched retrospective cohort study was carried out on 517 HIV-infected pregnant women who consecutively attended a university referral hospital between 1986 and 2010. Two controls were assigned for each case. They were matched by ethnicity, smoking, maternal age and educational level. Exclusion criteria were multiple pregnancy and active injection drug use (IDU). PTD was defined as delivery less than 37.0 weeks. Spontaneous PTD included preterm premature rupture of membranes. Iatrogenic delivery was considered if medically indicated. Factors associated with PTD among HIV-infected women were analyzed by logistic regression.
RESULTS: A total of 1557 pregnant women were analyzed (519 HIV-infected and 1038 noninfected). The incidence of PTD was 19.7% in HIV-infected women and 8.5% in controls [odds ratio (OR) 2.6; 95% CI 1.9-3.6]. There was a significantly higher incidence of both spontaneous [adjusted OR (AOR) 2.1; 95% confidence interval (CI) 1.5-3.0] and iatrogenic prematurity (AOR 3.2; 95% CI 1.8-5.7). Iatrogenic PTD was significantly associated with the use of HAART during the second half of pregnancy, whereas spontaneous PTD was not related to HAART.
CONCLUSION: There is a significant association of HIV infection with PTD, both spontaneous and iatrogenic PTD. HAART use was predominantly associated with iatrogenic PTD.

Entities:  

Mesh:

Year:  2012        PMID: 22008651     DOI: 10.1097/QAD.0b013e32834db300

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  41 in total

1.  Antiretrovirals in pregnancy: a note of caution.

Authors:  D Heather Watts; Lynne M Mofenson
Journal:  J Infect Dis       Date:  2012-10-12       Impact factor: 5.226

2.  Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial.

Authors:  Dorothy Sebikari; Mona Farhad; Terry Fenton; Maxensia Owor; Jeffrey S A Stringer; Min Qin; Nahida Chakhtoura; Benjamin H Chi; Friday Saidi; Neetal Nevrekar; Avy Violari; Tsungai Chipato; James A McIntyre; Dhayendre Moodley; Taha E Taha; Gerhard Theron; Mary Glenn Fowler
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-15       Impact factor: 3.731

3.  Predictors of adverse pregnancy outcomes in women infected with HIV in Latin America and the Caribbean: a cohort study.

Authors:  R Kreitchmann; S X Li; V H Melo; D Fernandes Coelho; D H Watts; E Joao; C M Coutinho; J O Alarcon; G K Siberry
Journal:  BJOG       Date:  2014-03-07       Impact factor: 6.531

4.  PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi.

Authors:  Maganizo B Chagomerana; William C Miller; Brian W Pence; Mina C Hosseinipour; Irving F Hoffman; Robert J Flick; Hannock Tweya; Soyapi Mumba; Frank Chimbwandira; Kimberly A Powers
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-01       Impact factor: 3.731

5.  Intestinal Barrier Dysfunction and Microbial Translocation in Human Immunodeficiency Virus-Infected Pregnant Women Are Associated With Preterm Birth.

Authors:  Rupak Shivakoti; Nikhil Gupte; Nathella Pavan Kumar; Vandana Kulkarni; Usha Balasubramanian; Ramesh Bhosale; Pradeep Sambrey; Aarti Kinikar; Renu Bharadwaj; Sandesh Patil; Sadaf Inamdar; Nishi Suryavanshi; Subash Babu; Robert C Bollinger; Amita Gupta
Journal:  Clin Infect Dis       Date:  2018-09-14       Impact factor: 9.079

6.  Human Immunodeficiency Virus Infection Is Associated With Preterm Delivery Independent of Vaginal Microbiota in Pregnant African Women.

Authors:  Muchaneta Gudza-Mugabe; Enock Havyarimana; Shameem Jaumdally; Kirsty Lee Garson; Katie Lennard; Andrew Tarupiwa; Fortunate Mugabe; Tarisai Marere; Rooyen T Mavenyengwa; Lindi Masson; Heather B Jaspan
Journal:  J Infect Dis       Date:  2020-03-16       Impact factor: 5.226

7.  Timing of Initiation of Antiretroviral Therapy and Risk of Preterm Birth in Studies of HIV-infected Pregnant Women: The Role of Selection Bias.

Authors:  Marie C D Stoner; Stephen R Cole; Joan Price; Jennifer Winston; Jeffrey S A Stringer
Journal:  Epidemiology       Date:  2018-03       Impact factor: 4.822

8.  Brief Report: Markers of Spontaneous Preterm Delivery in Women Living With HIV: Relationship With Protease Inhibitors and Vitamin D.

Authors:  Adriana Weinberg; Yanling Huo; Deborah Kacanek; Kunjal Patel; D Heather Watts; Diane Wara; Risa M Hoffman; Jelena Klawitter; Uwe Christians
Journal:  J Acquir Immune Defic Syndr       Date:  2019-10-01       Impact factor: 3.731

9.  Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

Authors:  Jennifer Y Chen; Heather J Ribaudo; Sajini Souda; Natasha Parekh; Anthony Ogwu; Shahin Lockman; Kathleen Powis; Scott Dryden-Peterson; Tracy Creek; William Jimbo; Tebogo Madidimalo; Joseph Makhema; Max Essex; Roger L Shapiro
Journal:  J Infect Dis       Date:  2012-10-12       Impact factor: 5.226

10.  Combination antiretroviral use and preterm birth.

Authors:  D Heather Watts; Paige L Williams; Deborah Kacanek; Raymond Griner; Kenneth Rich; Rohan Hazra; Lynne M Mofenson; Hermann A Mendez
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.